Dear respected members of the Korean Society of Pharmaceutical Sciences and Technology (KSPST),
First, I wish you a happy, healthy, and prosperous 2023! I am deeply indebted to all the members who always give unwavering support to the KSPST.
Since its foundation in 1971, our society has grown to be a vital and energetic community for domestic pharmaceutical scientists in academia and the pharmaceutical industry, all thanks to the effort and dedication of past presidents and members. With a history of half a century, our society has also welcomed opportunities for scientific leadership in the region. After the successful joint-hosting of the AFPS (the Asian Federation for Pharmaceutical Sciences) in 2013 and the AASP (the Asian Association of Schools of Pharmacy) in 2019, the Korean Local Chapter of the Controlled Release Society (CRS) is launched and playing a dynamic role in promoting the interactions at the international stage. As another milestone, the Journal of Pharmaceutical Investigation (JPI) has been enlisted as an SCIE journal, thanks to the multi-year dedicated efforts of the editor-in-chief, editorial board members, and members.
Now, the KSPST is at the junction of planning for a new 50-year development building on the past 50 years of history. Some of the changes brought by the COVID-19 pandemic are likely to stay and significantly impact how we think and communicate locally and globally. For 2023 the year of the rabbit, let us borrow the wisdom of the rabbit called 'Kyoto Three Caves.' We will prepare Plan B and Plan C and strive for the steady growth of society by placing another well-positioned stone in the series of stepping stones to a bright future.
In 2023, the board members of the society will always listen to the voice of the members for the continuing growth of the society and will do the very best to make our society open to all members. We ask for the support of our members so that the KSPST can grow further.